Studies and Consortia

On this page, you will find an overview of clinical trials and cohort studies and international consortia.

Are you interested in participating in one of our type 1 diabetes studies? 

further information

Type 1 Diabetes: Clinical Trials & Cohort Studies

Increased risk of type 1 diabetes: early detection - preventive action

Freder1k: early detection for babies (up to 4 months) in Bavaria, Lower Saxony, Saxony, and Thuringia

SINT1A study

The SINT1A study is a scientific study for infants at increased risk for type 1 diabetes.

Prevention trial for babies with increased risk of type 1 diabetes

POInT: for babies with increased genetic risk at the age of 4 to 7 months

Type 1 diabetes: early detection - early treatment

Fr1da-plus: early detection of type 1 diabetes for children in Bavaria aged 2 to 10 years

Early detection of type 1 diabetes for relatives

Germany-wide screening test for close relatives (1 to 21 years) of people with type 1 diabetes

Prevention trial for children with early stages of type 1 diabetes

Fr1da Insulin Intervention: for children with early-stage type 1 diabetes from 2 to 12 years

Prevention trial in relatives with early-stage type 1 diabetes

TrialNet Abatacept: for relatives (6 to 45 years) of people with type 1 diabetes

Intervention trial in newly manifested type 1 diabetes

DIABIL-2: Treatment with low-dose Interleukin-2 intends to stop the destruction of beta cells

Pioneering study in type 1 diabetes pathogenesis research

BABYDIAB: first birth cohort, has observed 1650 children of parents with type 1 diabetes from 1989 until today

Study to investigate environmental causes of type 1 diabetes

TEDDY: The Environmental Determinants of Diabetes in the Young

Investigation of frequency and characteristics of diabetes types

DiMelli (Diabetes Mellitus Incidence Cohort Registry): examines children and adolescents in Bavaria

Type 1 Diabetes: International Consortia


Global Platform for the Prevention of Autoimmune Diabetes


A network of scientists and pharmaceutical companies in Europe to investigate mechanisms of diabetes development


International research network for the prevention of diabetes progression in children with early stages of the disease


Network for Pancreatic Organ Donors with Diabetes